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Abstract
Background: Relapsing periodic arthritis is a general term used for a group of diseases with recurring and periodic
nature, in which the joints are intermittently involved. The aim of this study is to evaluation of the possible relationship
between MEFV gene mutations in intermittent arthritis of children which has recurring and periodic nature.
Methods: In this cross-sectional study we reviewed medical records of all patients with recurrent and periodic arthritis
referred to pediatric rheumatology clinic from 2003 to 2019.We excluded all patients with suspicious anamnesis and/or
positive history of FMF, JIA, gout, psoriasis, IBD and SLE. The peripheral blood of these patients was screened for the 12
common pathogenic MEFV gene variants (FMF Strip Assay, Vienna lab, Vienna, Austria) according to manufacturer’s
instructions.
Results: Among 195 recorded files, 11 patients were identified with idiopathic recurrent and periodic feature. 3
patients suffering from recurrent transient synovitis hip (RSH) and 8 patients were fully compatible with the Pasero and
Barbieri modified criteria of palindromic rheumatism (PR). Their mean age at diagnosis was 6.5 and 4.6 years and the
average follow-up was 2.6 and 6.6 years in PR and RSH patients, respectively. The most frequently involved joints were
knees and ankles in PR patients. The mean duration of attacks was 3.3 days in RSH patients and with various courses in
PR. The median number of attacks was 4.75 in PR and 3 in RSH patients per year. In PR group 7 patients showed no
mutations and all patients of RSH had these mutations; V726A, R761H, A744S as in heterozygote pattern.
Conclusion: An idiopathic relapsing periodic arthritis in children with exclusively hip involvement is a MEFV gene
related arthropathy; whereas with various joint attacks it could be considered as childhood PR.
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Background
The term Relapsing periodic arthritis has been proposed to
describe a group of arthritis that has recurring and periodic
nature, in which the joints are intermittently involved. It
may result from hereditary, acquired, or genetic and/or in-
fectious background [1]. These include crystalline arthropa-
thies, such as gout;inflammatory bowel disease (IBD)-
related arthritis; Behcet’s syndrome; Whipple’s disease;
relapsing polychondritis; intermittent hydrarthrosis and
arthropathy of familial Mediterranean fever (FMF) [2].
One of this arthritis is Palindromic Rheumatism (PR),
entity originally described by Hench and Rosenberg in
1944; however, is not well-defined accurately in pediatric
rheumatic diseases. It is a periodic idiopathic arthritis
characterized by sudden, transient, recurring, episodes
of mono or oligo-arthritis, is not associated with imaging
abnormalities, [3] and lasting from a few hours to sev-
eral days, which resolved spontaneously without residual
joint damage, and is associated with positive acute phase
reactant during attacks [4, 5].
The most commonly affected joints are the knees,
wrists, shoulders, ankles, and small joints of the hand.
The hips, feet and elbows are less often involved; how-
ever, PR can affect any joint [6].
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It affects adults of both sex [7] and due to the inter-
mittent and self-limited symptoms; diagnosis can be dif-
ficult or delayed. There is not distinct test could confirm
the diagnosis [2].
The MEFV gene is located on the short arm of chromo-
some 16 at position 13.3(16p 13.3) [8]. MEFV gene was
predominantly expressed in monocytes and granulocytes,
[9] both of which have major roles in the pathophysiology
of inflammatory and auto-inflammatory disease at the
acute phase and evolution of cytokines storm, an import-
ant immunological abnormality in KD [10].
It has been proposed that MEFV mutations might in-
crease the baseline of inflammation, induced the devel-
opment of inflammatory diseases, and affect the clinical
course of these disorders [11].
To clarify the correlation and relationship of idiopathic
relapsing periodic arthitis (IRPA) of childhood, such as
pediatric Palindromic Rheumatism with common patho-
genicMEFV gene mutaions, this study has been planned.
Material and methods
Patients
This is a retrospective, case series, cross sectional study and
included the patients with IRPA during 16-years from 2003
to 2019 at pediatric rheumatologic clinic. To identify pa-
tients, we reviewed all patients’ files with recurrent arthritis.
Patients with suspicious anamnesis and/or positive histories
of FMF, JIA, SLE, gout, psoriasis, IBD, celiac and infectious
causes such as brucellosis were excluded. None of the
patients and their first degree families had FMF and FMF
related symptoms. Arthritis had been confirmed by imaging
including ultrasound and or MRI further than labora-
tory tests.
Tel-Hashomer criteria have been used to diagnosis of
FMF, and for PR diagnosis, Pasero and Barbieri criteria
with some modification was committed (Table 1). Re-
trieved data were entered into a researcher designed
questionnaire, containing demographic, characteristics,
imaging different consultations and laboratory findings
of patients. Patients had taken treatment in short course
such as NSAID and Hydoxychloroquine (HCQ) inter-
mittently as DMARDS with suspicion of unclassified
and atypical JIA (CLASS 7) [1]. The study is complaint
with the Helsinki Declaration and was approved by the
local Ethics Committee under number (IR.ARUMS.-
REC.1396.95). Informed consent was obtained from all
the participants, and/or their parents.
Unlike in the adult population, the differential diagnosis
of pediatric periodic arthritis and PR may include a number
of clinical entities, such as playground and sport mechan-
ical injuries; Ehlers Danlos and joint hypermobility; post-
infectious arthritis, (such as post streptococcal reactive
arthritis); pain amplification syndromes and osteochondro-
sis. These possibilities, as well as other domestic disease
such as brucellosis were carefully ruled out by the treating
pediatric rheumatologists after extensive workup.
MEFV gene mutation analysis
Peripheral blood was collected from 11 patients and the
samples were screened for the 12 common pathogenic
variants(E148Q, P369S, F479 L, I692del, M680I(G/C),
M680I(G/A), M694 V, M694I, K695R, V726A, A 744S,R
761H) by an RDB assay (FMF Strip Assay, Vienna lab,
Vienna, Austria) according to manufacturer’s instruc-
tions, from fresh blood sampling simultaneously at gen-
etic lab center of the hospital.
Result
Among 195 recorded files, 11 patients matched IRPA
and were reviewed thoroughly. First group included 8
patients who their symptoms were compatible with PR,
6 of them were male and second group contained 3 pa-
tients suffering from recurrent synovitis of hip (RSH).
Demographic characteristics of these patients are pre-
sented in Table 2.
In the clinical evaluations of patients with PR; hip,
knee and ankle joints involvements were observed in
1(12.5%), 3(37.5%) and 3(37.5%) patients, respectively. In
one patient, in each episode, different pattern of joints
(hip, knee, ankle, and wrist) were involved.
Laboratory and radiographic findings
In PR, during flares, C-reactive protein (CRP) and the
erythrocyte sedimentation rate (ESR) in 5 patients was
higher than normal. RF, antinuclear antibodies (ANA),
HLAB27, Anti–dsDNA, Anti-ccp, and ANCA were
negative in patients. Ophthalmological examination had
normal results.
In RSH, during flares, CRP and ESR were near normal.
RF and ANA, HLAB27, Anti–dsDNA, Anti-ccp, and
ANCA were negative. X-ray was normal, although the
Ultrasound showed the synovitis with variable degree of
synovial effusion. Radioisotope scans were normal.
Discussion
This study attempts to assess and characterize idiopathic
relapsing and periodic arthritis (IRPA) in pediatric and
Table 1 Diagnostic criteria for palindromic rheumatism
Pasero&Barbieri (1986) [12]
▪ A history of brief sudden-onset, recurrent attacks of monoarthritis
▪ Direct observation of one attack by a physician
▪ Three or more joints involved in different attacks
▪ More than five attacks in the last 2 years
▪ Negative x-rays, acute phase reactants and rheumatoid factor
▪ Exclusion of other recurrent monoarthritis: gout; chondrocalcinosis;
intermittent hydrarthrosis; and periodic diseases
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clarify their possible relationship with MEFV gene vari-
ant alleles. This study includes 8 patients who their fea-
tures were compatible with Palindromic Rheumatism
and 3 patients with RSH.
Most of PR group were male and the knee and ankle
were the most commonly affected joints. FMF is not a rare
disease in this area, [13] and FMF related arthritis is not
uncommon features; however, among PR group, seven pa-
tients had negative results for MEFV gene mutations. It
was observed only in one patient with PR features (12.5%)
as heterozygote V726A mutation. This mutation is a very
rare variant of healthy and normal population of this area
(2.2%)(our under published data; however, its original lan-
guage publishing is available at www.arums.ac.ir Accord-
ing to Beheshtian’s report that has been planned from all
part of Iran, in northwest and Azeri healthy people the
frequency of MEFV alleles were 13.2 and 10.3% respect-
ively. From total 9 mutant alleles 7 were E148Q and the
rest were P396Q, and V726A, whereas R761H and A744S
alleles have not been shown among healthy people [14].
Whereas in our study overall mutations alleles were 25
and 18.3% of them was E148Q.)
This study displayed lower frequency rate of MEFV
variants alleles in childhood IRPA with PR phenotype.
There is not similar pediatric study in our knowledge;
however, in a study by Cañete et al.,in adults [15] 65 pa-
tients with Palindromic Rheumatism were evaluated,
12.3% of patients with PR had MEFV gene mutations
(carried at least 1 mutated MEFV allele). Kobayashi et al.
reported the E148Q allele is the most common encoun-
tered allele in patients with PR [16].
Cabrera-Villalba concluded that in a number of pa-
tients with Palindromic Rheumatism MEFV gene muta-
tions can be observed, but this mutation is not likely to
be related to the pathogenesis of the disease [1].
In our study, all 3 patients with RSH had MEFV gene
mutations that including R761H, V726A, and A744S in
heterozygote form which are not variants of our healthy
and normal population (our under published data).
Although RSH is not a common condition in children
and this study include only three cases, the high rates of
MEFV mutations in RSH patients emphasis the potential
role of MEFV gene alleles as a pathogenic background in
this group. Peleg suggests the possible role of MEFV gene
in different rheumatic disease other than FMF [17],
accordingly RSH could be considered as a MEFV gene
related arthritis.
Although the outcome of children with one MEFV mu-
tation in the populations, in which FMF carrier frequency
is high, continues to be a challenge for physicians, Makay
recommend periodic clinical visits, particularly if the child
has a pathogenicMEFV mutation [18].
It is possible that some of these patients develop FMF
related symptoms in the future, during their third and or
Table 2 Demographic data of IRPA patients
Palindromic Rheumatism (PA) Recurrent synovitis of the hip (RSH)
The mean age (years) 10.12 10.33
Age at diagnosis (years) 6.5 4.6
Male/female (N) 6/2 1/2
Duration of follow-up a (years) 2.6 6.6
Number of episodes per year 4.75 3
Attack intervals (mean) month 3.1(n = 7) 1.6
Variable(n = 1)
Systemic symptoms during attacks (%) 37.5% 0
Morning stiffness during attacks (%) 12.5% 0
Join involvement Hip(n = 1)
Knee(n = 3)
Ankle(n = 3) Hip(n = 3)
Variable(n = 1)
Joint pattern Monoarticular Monoarticular
Mutations Non (n = 7) A744S(Female)
V726A(n = 1/male) R761H(Female)
V726A(Male)
Average duration of episodes 3.5 days(n = 4)
2.3 h(n = 3) 3.3 days
Variable(n = 1)
aDefined as the time from first presentation to last follow-up
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more decades. If it occurs we will confront with a new
dilemma; whether RSH is the first presentation of FMF-
related arthropathy, although it has not been reported
up to now, and or it is a separate entity and co-existed
with FMF.
Conclusion
In our opinion, an idiopathic relapsing periodic arthritis in
children with exclusively hip involvement is a MEFV gene
related arthropathy; whereas with various joint attacks it
could be considered as childhood PR, a condition that has
not been affected byMEFV gene related inflammation.
Although the number of patients in these results is too
low and a large sample size will be required to confirm
this finding, however; IRPA is not a common condition
in children.
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